FDA Extends Comment Period on GDUFA Guidance After Website Outage

Drug Industry Daily
A A
Drugmakers have 14 additional calendar days to comment on recently revised GDUFA question-and-answer guidance after technical difficulties prevented stakeholders from submitting comments on Regulations.gov.

To View This Article:

Login

Subscribe To Drug Industry Daily